Prairie Sky Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$349K Hold
7,546
0.19% 51
2025
Q1
$460K Hold
7,546
0.27% 42
2024
Q4
$427K Hold
7,546
0.26% 43
2024
Q3
$390K Sell
7,546
-11
-0.1% -$516 0.22% 50
2024
Q2
$314K Hold
7,557
0.19% 56
2024
Q1
$410K Sell
7,557
-603
-7% -$30.7K 0.25% 46
2023
Q4
$419K Sell
8,160
-86
-1% -$4.51K 0.27% 40
2023
Q3
$479K Hold
8,246
0.34% 39
2023
Q2
$527K Buy
+8,246
New +$553K 0.36% 37

Other funds holding BMY

Prairie Sky Financial Group's BMY Position: Q2 2025 in Review

Prairie Sky Financial Group held its Bristol-Myers Squibb (BMY) position steady in Q2 2025 at 7,546 shares worth $349K. The position accounts for 0.19% of the portfolio, ranked #51.

Prairie Sky Financial Group first reported a position in BMY in Q2 2023 and has held it in 9 quarters since. The position peaked at $527K in Q2 2023. 2,297 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • Prairie Sky Financial Group held 7,546 shares of Bristol-Myers Squibb worth $349K as of Q2 2025.
  • Prairie Sky Financial Group left its Bristol-Myers Squibb share count unchanged in Q2 2025.
  • Bristol-Myers Squibb made up 0.19% of Prairie Sky Financial Group's portfolio in Q2 2025, its #51 holding.
  • Prairie Sky Financial Group first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 9 quarters since.
  • Prairie Sky Financial Group's Bristol-Myers Squibb position peaked at $527K in Q2 2023.
  • 2,297 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Prairie Sky Financial Group's 13F filing for Q2 2025, filed 28 Jul 2025.